Norbert G. Riedel

President, Chief Executive Officer, Director at Aptinyx, Inc.

Norbert G. Riedel

Norbert G. Riedel

President, Chief Executive Officer, Director at Aptinyx, Inc.

Overview
Career Highlights

Aptinyx, Inc.
Naurex, Inc.

RelSci Relationships

5604

Number of Boards

18

Birthday

1958

Age

62

Relationships
RelSci Relationships are individuals Norbert G. Riedel likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Jazz Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at PathoCapital LLC

Relationship likelihood: Strong

Co-Founder at Longitude Capital Management Co. LLC

Relationship likelihood: Strong

Chief Financial & Business Officer at Aptinyx, Inc.

Relationship likelihood: Strong

Partner & Head of Growth Equity Investments at Adams Street Partners LLC

Relationship likelihood: Strong

Founder at Beecken Petty O'Keefe & Co. LP

Relationship likelihood: Strong

Managing Partner at Baxalta Ventures

Relationship likelihood: Strong

Director of the Falk Center at Molecular Therapeutics, Inc.

Relationship likelihood: Strong

Director & Founding Member at MATTER Chicago

Relationship likelihood: Strong

Chief Executive Officer at MATTER Chicago

Relationship likelihood: Strong

Paths to Norbert G. Riedel
Potential Connections via
Relationship Science
You
Norbert G. Riedel
President, Chief Executive Officer, Director at Aptinyx, Inc.
Education
Ph.D in Biochemistry
Class of 1983

The Goethe University Frankfurt (full German name: Johann Wolfgang Goethe-Universität Frankfurt am Main) is a university which was founded in 1914 as a Citizens' University, which means that, while it was a State university of Prussia, it had been founded and financed by the wealthy and active liberal citizenry of Frankfurt am Main, a unique feature in German university history. It was named in 1932 after one of the most famous natives of Frankfurt, the poet and writer Johann Wolfgang von Goethe. Today, the university has 38,000 students, on 4 major campuses. Until now Goethe University Frankfurt has produced 14 Nobel Prize winners, including 8 graduates.Being research focused, the university is an affiliate of 11 academics, who have been awarded the Gottfried Wilhelm Leibniz Prize, the highest research prize in Germany.

Memberships
Member
Current

Governor Pat Quinn created the Illinois Innovation Council in 2011 to identify and advance strategies that accelerate innovation, economic growth, and job creation.

Member
2009 - Prior
Career History
President, Chief Executive Officer, Director
2015 - Current

Aptinyx Inc. is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.

Adjunct Professor
Current

Northwestern University Feinberg School of Medicine, founded in 1859, attracts talented individuals to its faculty, staff, and student body through its cutting-edge research initiatives, superb clinical affiliates, global outlook, and innovative curriculum. Located in the heart of Chicago’s Magnificent Mile, Feinberg has built a national reputation for excellence through a strong history of collaborative, interdisciplinary medical education and research, and along with Northwestern Memorial Hospital and Northwestern Medical Faculty Foundation is part of the premier academic medical center known as Northwestern Medicine. Feinberg stands out among the nation's research-intensive medical schools and consistently receives high marks in U.S. News & World Report surveys. Through its affiliates, it provides patient care to thousands of individuals every year, and plays an integral part in the communities it serves.

President, Chief Executive Officer & Director
2014 - 2015

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

Boards & Committees
Member, Board of Directors
Current

MATTER is a community of healthcare entrepreneurs and industry leaders working together in a shared space to individually and collectively fuel the future of healthcare innovation. MATTER's mission is to proactively connect and promote collaboration among entrepreneurs, scientists, physicians and industry partners to bring next-generation products and services to market that improve quality of care and save lives.

Director
2000 - Prior

Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY.

Director
2001 - Current

The Illinois Biotechnology Innovation Organization (iBIO) is a life sciences industry association of more than 500 members comprised of life sciences companies, universities, academic institutions, service providers and others dedicated to making Illinois and the surrounding Midwest one of the world’s top life sciences centers.

Trustee
Prior

The Chicago Symphony Orchestra (CSO) was founded by Theodore Thomas in 1891. The ensemble makes its home at Orchestra Hall in Chicago and plays a summer season at the Ravinia Festival. The music director is Riccardo Muti, who began his tenure in 2010. The CSO is one of five American orchestras commonly referred to as the "Big Five".

Transactions
Details Hidden

Aptinyx, Inc. raised money in a private placement transaction

Details Hidden

Aptinyx, Inc. raised money in a private placement transaction

Details Hidden

Naurex, Inc. raised money in a private placement transaction

Investments
Details Hidden

Aptinyx Inc. is a clinical stage biopharmaceutical company. It engages in the discovery, development, and and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Norbert G. Riedel. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Norbert G. Riedel's profile does not indicate a business or promotional relationship of any kind between RelSci and Norbert G. Riedel.